Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Tissue Regeneration
AddedFeb 18, 2024
UpdatedJun 18, 2026
Tissue Regeneration

Tissue Regeneration

Pre-Seed

Tissue Regeneration Inc: Pioneering human tissue replacement and medical devices in New Haven, CT.

HQ
Medford, MA, US
Overview
Compare
Fundraising
Employees

Tissue Regeneration Inc is a medical devices company focused on pioneering human tissue replacement. Based in New Haven, CT, the company aims to revolutionize the field of regenerative medicine by developing innovative solutions for tissue repair and replacement. Their products and services target the healthcare market, addressing critical needs in medical treatments and surgeries.

Tissue Regeneration Inc has made significant strides in the field of regenerative medicine, contributing to advancements in human tissue replacement technologies. Their impactful work has positioned them as a key player in the medical devices industry, enhancing patient outcomes and pushing the boundaries of medical science.

Tissue Regeneration - Similar Companies

Tissue Regeneration Systems logo

Tissue Regeneration Systems

tissuesys.com

Histogen logo

Histogen

histogen.com

BiomedInnovations logo

BiomedInnovations

BioTissue logo

BioTissue

biotissue.com

RegenX logo

RegenX

Cardiovate logo

Cardiovate

Sofregen Medical logo

Sofregen Medical

TissueForm logo

TissueForm

tissueforminc.com

RegeneRx Biopharmaceuticals logo

RegeneRx Biopharmaceuticals

Endogena Therapeutics logo

Endogena Therapeutics

Regenemed logo

Regenemed

regenemed.com

Harvard Apparatus Regenerative Technology logo

Harvard Apparatus Regenerative Technology

Tissue Genesis logo

Tissue Genesis

tissuegenesis.com

Lynch Regenerative Medicine logo

Lynch Regenerative Medicine

Ventrinova logo

Ventrinova

Tissue Regeneration - Quick Facts

Who are Tissue Regeneration's competitors?

Companies similar to Tissue Regeneration include Tissue Regeneration Systems, Histogen, BiomedInnovations and BioTissue.

Where is Tissue Regeneration's headquarters located?

Tissue Regeneration's headquarters is located in Medford, MA, US.

When was Tissue Regeneration's last funding round?

Tissue Regeneration's most recent funding round was for $750k (USD) in November 2003.

How much has Tissue Regeneration raised to-date?

As of Nov 26, 2003, Tissue Regeneration has raised a total of $750k (USD).

How many employees does Tissue Regeneration have?

Tissue Regeneration has 30 employees as of Feb 5, 2024.

Tissue Regeneration - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Transactional
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified